Launched in 2018, Medical Cannabis Week was imagined as a way to connect patients, practitioners and industry in dialogue about the future of medical cannabis. This year’s program will focus on key components of the medical cannabis space, with specific conversations focused on innovation, international implications and opportunities, current research, Atlantic Canada as a hub for research and development as well as the relationship between cannabis and sport.
The opening evening will be the first of a series called Medical Cannabis Talks – a series of short, focused presentations on varying aspects of medical cannabis, from technology and innovation to animal health, cannabis and sport and research. The talks will be in one of two formats – either 5-minute talks presented by an individual speaker or a 7-minute, one-on-one interview-style fireside chat.
The line up of speakers includes:
Pamela Hadfield, Co-Founder, HelloMD
John Prentice, Founder & CEO, Ample Organics
Stephanie Karasick, Founder, Strainprint Technologies
Diane Scott, CEO, Jamaican Medical Cannabis Corporation + Jay Rosenthal, Business of Cannabis
Dr. Evan Lewis, Director, Neurology Centre of Toronto
Nadine Hare + Emily Simmonds, Fresh Squeezed Ideas
Strategy Associate, Fresh Squeezed Ideas
Dr. Lyle Oberg, Chief Policy + Medical Officer, Flowr
Janet Yale, President + CEO, The Arthritis Society + Jay Rosenthal, Business of Cannabis
Dr. Ian Sandler, DVM, Co-Founder + CEO, Grey Wolf Animal Health
Shekhar Parmar, Founder + CEO, Harvest Medicine
Chris Churchill-Smith, CEO, Canada House Wellness Group
Robert Frid, Executive Director, Medicinal My Way + James O’Hara, Past President + CEO, CFAMM
